文献速递食管与纵隔外科

食管癌食管切除术后数十年长期生存的决定因素

Determinants of Long-term Survival Decades After Esophagectomy for Esophageal Cancer.
PubMed 文献 · Ann Thorac Surg · 2023-06-22

本研究回顾了2000年1月5日至2010年12月30日在本机构因原发性食管癌行食管切除术的870例成人患者,中位随访15年,15年总生存率为25.2%,无复发生存率为57.96%,无病生存率为24.21%。多因素分析识别了与总生存降低相关的可改变和不可改变因素,结论认为患者术后存活5年后复发罕见,在高容量中心遵循美国国家综合癌症网络(NCCN)指南并采用多学科团队治疗可获得长期生存,其生存率是先前国家数据库文献报告的两倍。

要点

  • 食管切除术后15年总生存率为25.2%,无复发生存率为57.96%,无病生存率为24.21%。
  • 可改变因素中,新辅助治疗、晚期病理分期、切缘阳性、再次手术干预和需要输血与总生存降低相关。
  • 患者存活5年后复发罕见,术后6年总生存概率为0.920(95%CI 0.895-0.947)。

核心结论

  • 患者存活5年后复发罕见,在高容量中心遵循NCCN指南并采用多学科团队治疗可获得长期生存,其生存率是先前国家数据库文献报告的两倍。

研究设计与样本

  • 回顾性队列研究,纳入2000年1月5日至2010年12月30日在本机构因原发性食管癌行食管切除术的870例成人患者,采用单因素Cox模型和多因素logistic回归分析。

主要发现

  • 中位随访15年,15年总生存率为25.2%,无复发生存率为57.96%,无病生存率为24.21%。
  • 总生存降低与不可改变因素相关:年龄较大、男性、当前吸烟状态、冠心病史、晚期临床分期和肿瘤位置。
  • 总生存降低与可改变因素相关:使用新辅助治疗、晚期病理分期、切缘阳性、再次手术干预和需要输血。
  • 食管切除术后6年总生存概率为0.920(95%CI 0.895-0.947),复发时间概率为0.988(95%CI 0.976-1.000),共17例复发和201例死亡。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Long-term survival in esophagectomy patients with esophageal cancer is low due to tumor-related characteristics, with few reports of modifiable variables influencing outcome. We identified determinants of overall survival, time to recurrence, and disease-free survival in this patient cohort. METHODS: Adult patients who underwent esophagectomy for primary esophageal cancer from January 5, 2000, through December 30, 2010, at our institution were identified. Univariate Cox models and multivariable logistic regression analyses were used to identify associations between modifiable and unmodifiable patient and clinical variables and outcome of survival for the total cohort and a subgroup with locally advanced disease. RESULTS: We identified 870 patients with esophageal cancer who underwent esophagectomy. The median follow-up time was 15 years, and the 15-year overall survival rate was 25.2%, survival free of recurrence was 57.96%, and disease-free survival was 24.21%. Decreased overall survival was associated with the following unmodifiable variables: older age, male sex, active smoking status, history of coronary artery disease, advanced clinical stage, and tumor location. Decreased overall survival was associated with the following modifiable variables: use of neoadjuvant therapy, advanced pathologic stage, resection margin positivity, surgical reintervention, and blood transfusion requirement. The overall survival probability 6 years after esophagectomy was 0.920 (95% CI, 0.895-0.947), and time-to-recurrence probability was 0.988 (95% CI, 0.976-1.000), with a total of 17 recurrences and 201 deaths. CONCLUSIONS: Once patients survive 5 years, recurrence is rare. Long-term survival can be achieved in high-volume centers adhering to National Comprehensive Cancer Network guidelines using multidisciplinary care teams that is double what has been previously reported in the literature from national databases.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Abou Chaar MK, Godin A, Harmsen WS, et al. Determinants of Long-term Survival Decades After Esophagectomy for Esophageal Cancer. Ann Thorac Surg. 2023. PMID: 37353102. doi:10.1016/j.athoracsur.2023.05.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。